Salvin Dental Specialties, LLC – Trademark Portfolio
Entity Type: 16
Salvin Dental Specialties, LLC owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ORAFOAM, ALLOSCULPT, VITALERTKIT, ALLOSPARK-GF, and CODEBLUE MONITORING SERVICE. Of these, 5 are registered. The portfolio spans 3 Nice Classification classes, led by Class 10 (Medical Apparatus) and Class 5 (Pharmaceuticals). Headquartered in Charlotte, NC.
3450 Latrobe Drive
Charlotte, NC 28211
Showing of trademarks Trademarks
Trademark Classifications
Salvin Dental Specialties, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Salvin Dental Specialties, LLC have?
Salvin Dental Specialties, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does Salvin Dental Specialties, LLC file in?
Salvin Dental Specialties, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Salvin Dental Specialties, LLC's most well-known trademarks?
Salvin Dental Specialties, LLC's registered trademark portfolio includes well-known marks such as ORAFOAM, ALLOSCULPT, VITALERTKIT, ALLOSPARK-GF, and CODEBLUE MONITORING SERVICE. These are among 5 currently registered trademarks in the portfolio.
What is Salvin Dental Specialties, LLC's trademark registration success rate?
Salvin Dental Specialties, LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.